Beam Therapeutics (BEAM) Return on Sales [ROS] (2019 - 2026)
Beam Therapeutics' Return on Sales [ROS] was -25827.14% in Q2 2026, down 24407.92 percentage points from -1419.22% a year earlier and down 25489.33 percentage points from the prior quarter.
Powered by 
Analysis
Beam Therapeutics (BEAM) Return on Sales [ROS] (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Beam Therapeutics' Return on Sales [ROS] was -242.27% through Jun 30, 2026, up 497.67 percentage points year-over-year; for FY2025, it was -274.57%, up 379.68 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of +552892.10 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was -654.25% in FY2024 (-607.53 pp), -46.73% in FY2023 (+508.89 pp), -555.61% in FY2022 (+201.40 pp) and -757.01% in FY2021 (+552409.66 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Sales [ROS] since Q2 2021.
- Compared with a year earlier, Return on Sales [ROS] was higher in two of the last eight quarters, with an average year-over-year change of -3075.48 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q1 2022 (a gain of 3338646.00 percentage points); the worst was Q2 2026 (a drop of 24407.92 percentage points).
- Per Business Quant data, BEAM's Return on Sales [ROS] in the three quarters before Q2 2026 was -337.81% (Q1 2026), -15.29% (Q4 2025) and -1307.60% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - | -25,827.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25,827.14% |
| Mar 31, 2026 | -337.81% |
| Dec 31, 2025 | -15.29% |
| Sep 30, 2025 | -1,307.60% |
| Jun 30, 2025 | -1,419.22% |
| Mar 31, 2025 | -1,596.87% |
| Dec 31, 2024 | -332.71% |
| Sep 30, 2024 | -746.40% |
| Jun 30, 2024 | -891.06% |
| Mar 31, 2024 | -1,405.29% |
| Dec 31, 2023 | 42.02% |
| Sep 30, 2023 | -629.72% |
| Jun 30, 2023 | -507.79% |
| Mar 31, 2023 | -408.66% |
| Dec 31, 2022 | -444.10% |
| Sep 30, 2022 | -577.90% |
| Jun 30, 2022 | -492.23% |
| Mar 31, 2022 | -904.00% |
| Dec 31, 2021 | -124.31% |
| Sep 30, 2021 | -9,126.34% |
API Access
Beam Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();